InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,634.19
(
0.89%
)
US TECH 100
19,875.20
(
1.01%
)
Dow Jones
40,068.13
(
0.79%
)
Brent Oil
85.35
(
0.28%
)
Bitcoin
58,005.42
(
1.14%
)
Post# of 203914
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

FELLER

Send PM Follow Ignore
Followers 136
Posts 5060
Boards Moderated 0
Alias Born 01/31/2012

FELLER

Re: None

Thursday, 01/19/2017 9:40:18 AM

Thursday, January 19, 2017 9:40:18 AM

Post# of 203914
Let's not forget this from the Annual Letter:

The Company’s longer-term objectives include the commencement of clinical trials using its proprietary sublingual tablet as the basis for cannabinoid-based drug trials for multiple myeloma, Post-Traumatic Stress Disorder (PTSD), and fibromyalgia.

2017 is going to be a year of gaaaaains!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM

ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM

Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!